Home Research Feeds Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions

Relationship between the Cervical Microbiome, HIV Status, and Precancerous LesionsOriginal paper

Researched by:

  • Karen Pendergrass

Last Updated: 2026-07-05

Karen Pendergrass
Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Read More
Location
United Republic of Tanzania
Sample Site
Uterine cervix
Species
Homo sapiens

What was studied?

This study asked how the cervical bacterial microbiome relates to HIV status and precancerous cervical lesions. Cytobrush samples were taken directly from cervical lesion sites, not by lavage. The V4 region of the 16S rRNA gene was amplified and deep sequenced. Communities were compared across HIV status and cervical cytology grade. Cytology was graded as normal (NILM), low-grade (LSIL), or high-grade (HSIL) squamous intraepithelial lesions. Analyses used alpha and beta diversity, LEfSe, and odds ratios.

Who was studied?

The cohort was 144 Tanzanian women screened for cervical cancer, average age 37 years. Forty-one were HIV positive and 103 were HIV negative. All 41 HIV-positive women were also HPV positive. Cytology gave 23 normal, 72 low-grade, and 50 high-grade lesion samples. Samples came from Dar es Salaam and rural clinics in Chalinze and Bagamoyo. This was a cross-sectional human study in a high-burden setting.

What were the most important findings?

HIV-positive women had significantly higher cervical bacterial richness than HIV-negative women (p = 0.009). Mycoplasma rose with lesion severity, from 0.3% of reads in normal HIV-negative cervices to 1.3% in high-grade lesions. Among HIV-positive women the shift was larger, from 0.2% in normal cervices to 5.0% in high-grade lesions. Lactobacillus was the dominant genus overall at 21.9% of reads but declined with lesions. HIV positivity, high-grade lesions, more than five sexual partners, and prior sexually transmitted infection were significant risk factors for a positive visual inspection. Firmicutes was the predominant phylum at 41.3% of reads.

What are the greatest implications of this study?

The findings suggest a chronic Mycoplasma infection may help sustain the inflammation that promotes HPV-related cervical lesions. Higher bacterial richness marked HIV-positive cervices. By sampling lesions directly, the study argues bacteria at lesion sites are more relevant to disease progression. These are associations, not proof that Mycoplasma causes lesions. The authors note that certain cervical microbiota might one day serve as diagnostic markers of cervical cancer risk. Longitudinal and metagenomic studies are needed.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.

Join the Waitlist and help shape the future of microbiome medicine.